While it has been shown to promote metastasis and macrophage-independent invasion [49], and act as an effective target for antibody bound nanoparticles for drug delivery in triple negative breast cancer [50], HBEGF is interesting due to its relationship with the Epidermal Growth Factor (EGF). The gene discussed is EGF; the disease is triple-negative breast carcinoma.